+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist



Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist



European Journal of Pharmacology 53(4): 351-358



The intravenous injection of isoprenaline (10 nmole/kg) into conscious beagle dogs caused significant increases in the blood level of lactate, glucose, FFA, insulin and cyclic AMP. These metabolic alterations induced by isoprenaline were blocked completely by pretreatment of the dog with propranolol (1 mg/kg). Butoxamine (10 mg/kg) antagonized isoprenaline-induced increases in glucose, lactate and insulin, but not the increases in FFA. Practolol (10 mg/kg) diminished the increase in blood FFA very strongly. Salbutamol, which is known to be an agonist of the beta 2-subtype in its bronchomotor and cardiovascular actions, produced marked increases in the blood concentrations of lactate, glucose and insulin but were without effect on the FFA level. Thus metabolic responses of conscious beagle dogs to beta-adrenoceptor agonists appeared to depend differentially on two types of beta-adrenoceptors: beta1-adrenoceptors are largely involved in lipolysis while beta2-adrenoceptors are involved in the regulation of blood glucose metabolism and insulin secretion. A new beta-adrenoceptor agonist, 5-(1-hydroxy-2-isopropylaminobutyl)-8-hydroxycarbostyril hydrochloride hemihydrate (Procaterol), was classified as a beta 2-agonist, because it markedly increased plasma concentrations of glucose, lactate and insulin but increased the plasma level of FFA to a lesser degree. The order of potency of beta2-agonists was procaterol greater than salbutamol greater than trimetoquinol. Metabolic responses of beagle dogs would be useful for appreciating the selectivity and potency of beta-adrenoceptor agonists and antagonists.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 038910731

Download citation: RISBibTeXText

PMID: 33812


Related references

Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles. Journal of Pharmacological Sciences 107(4): 393-400, 2008

Effects of the Gln27Glu- and the Arg16Gly-beta2-adrenoceptor polymorphisms on agonist-induced desensitization of beta2-adrenoceptor-mediated venodilation in vivo. British Journal of Clinical Pharmacology 55(4): 442, 2003

Synthesis and evaluation of procaterol, a selective agonist for detection of pulmonary beta2-adrenoceptors with PET. Journal of Nuclear Medicine 40(5 SUPPL ): 123P, 1999

Agonist-induced desensitization of beta2-adrenoceptor-mediated venodilation and cardiac responses in subjects with the Thr164Ile beta2-adrenoceptor. British Journal of Clinical Pharmacology 55(4): 442, 2003

Cyclic nucleotide phosphodiesterase type 2 regulates the contractile effect mediated by beta2-adrenoceptors, but not those mediated by beta1-adrenoceptors in human right atria. British Journal of Pharmacology 135(Proceedings Supplement): 318P, 2002

The selective action of beta-adrenoceptor blocking drugs and the nature of beta1 and beta2 adrenoceptors. British Journal of Pharmacology 59(1): 83-93, 1977

The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. British Journal of Pharmacology 138(3): 521-529, 2003

Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology 363(1): 87-93, 2001

Relaxation of cat trachea by beta-adrenoceptor agonists can be mediated by both beta1- and beta2-adrenoceptors and potentiated by inhibitors of extraneuronal uptake. British Journal of Pharmacology 78(2): 417-424, 1983

Effects of a new selective beta2-/beta3-adrenoceptor agonist, KUL-7211, on intraureteral pressure and afferent renal nerve activity in dogs. Japanese Journal of Pharmacology 88(Supplement 1): 248P, 2002

Ligands at beta2-, beta3-, and the low-affinity state of beta1-adrenoceptors block the alpha1-adrenoceptor-mediated constriction in human pulmonary and rat mesenteric arteries. Journal of Cardiovascular Pharmacology 46(1): 76-82, 2005

Synthesis and biodistribution of [11c]procaterol, a beta2-adrenoceptor agonist for positron emission tomography. Applied Radiation and Isotopes 52(4): 857-863, 2000

Tracheal relaxing effects and beta2-selectivity of S1319, a novel beta2-adrenoceptor agonist from the marine sponge Dysidea sp. Japanese Journal of Pharmacology 79(SUPPL 1): 263P, 1999

The beta2-selective agonist zinterol enhances L-type calcium current via beta1-adrenoceptor stimulation in mouse ventricular myocytes. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4 SUPPL): R101, 1998

Physiological antagonism between ventricular beta1-adrenoceptors and alpha1-adrenoceptors but no evidence for beta2- and beta3-adrenoceptor function in murine heart. British Journal of Pharmacology 136(2): 217-229, 2002